Article Versions Notes

Konopleva MV, Borisova VN, Sokolova MV, Semenenko TA, Suslov AP. Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro. Vaccines. 2022; 10(2):235. https://doi.org/10.3390/vaccines10020235

Konopleva, Maria V., Vera N. Borisova, Maria V. Sokolova, Tatyana A. Semenenko, and Anatoly P. Suslov. 2022. "Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro" Vaccines 10, no. 2: 235. https://doi.org/10.3390/vaccines10020235

Konopleva, M. V., Borisova, V. N., Sokolova, M. V., Semenenko, T. A., & Suslov, A. P. (2022). Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro. Vaccines, 10(2), 235. https://doi.org/10.3390/vaccines10020235